-
UK PM launches bid to help homeless, donating part of his wages
-
All Blacks must get 'everything right' to beat Springboks, says legend Fitzpatrick
-
Golden Shoe winner Kane hopes for Ballon d'Or after 'best season ever'
-
Robinson and Tongue star as Pakistan all out for 171 in England opener
-
Kyiv's ex-defence chief makes risky bet by venturing into electoral grounds
-
Lake Zurich sees water level hit record low amid drought
-
Coventry have survival inspiration says Lampard
-
Merck and Moderna's tailored cancer drug curbs melanoma recurrence in trial
-
Reijnders leaves Man City for Saudi's Al Qadsiah
-
Referees chief Webb wants clamp-down on Premier League set-piece grappling
-
Trump says will meet North Korea's Kim later this year
-
Robinson makes history as Pakistan collapse against England
-
Stocks waver, dollar drops as US Treasury moves to lower bond yields
-
Alvarez can win back Atletico fans in two games: club chief
-
France recalls rare disease drug Tavneos after deaths
-
Oldest human brain cells grown in lab 'recorded passage of time'
-
Arsenal agree to sign Villa defender Konsa: reports
-
7,300 excess deaths and counting in France's historically hot summer
-
Evacuation orders lifted in Belgian wildfire zone
-
Ukraine MPs approve new defence minister after divisive reshuffle
-
UK media skewered for 'hounding' black academic
-
North Korea leader's sister says 'unaware' of reported Kim-Trump communication
-
More than 7,300 excess deaths in France's historically hot summer so far
-
Russia, Ukraine exchange 103 captured soldiers each
-
US socialists score shock Florida win as Trump picks stumble
-
Sainz signs new contract with F1 team Williams
-
Iran warns Gulf countries against helping US after UAE cuts trade ties
-
Playing at Real Madrid 'not for everyone': Bernardo Silva
-
Senior FIFA official withdraws support from embattled Infantino
-
As election nears, Israelis fear polarisation could spark violence
-
Lawson replaces injured Hadjar for Red Bull at Dutch GP
-
Bayern's Hoeness 'speechless' after second Musiala collapse
-
Robots sort packages and serve fast food at Beijing showcase
-
Reijnders leaves Man City for Saudi's Al Qadsiah: source
-
Leeds sign Swiss defender Elvedi from Monchengladbach
-
Arsenal chief expects Arteta to sign new contract 'very shortly'
-
Robinson double rocks Pakistan in first Test before rain stops play
-
Oil rises, stocks waver amid tech sell-off
-
Queen Camilla says was 'difficult' keeping King Charles' cancer private
-
Belgian fire of the century 'encircled' but fight goes on
-
UK PM launches bid to get rough sleepers off streets by Christmas
-
Japan target record medal haul at home Asian Games
-
England bowl against Pakistan in first Test of post-Bazball era
-
ICC says US sanctions 'flagrant attack' on court independence
-
Villa sign Japanese 'keeper Suzuki, Italian defender Ruggeri
-
Kyrgios admits 'huge mistake' after failing test for cocaine
-
Injury-plagued Pogba released by Monaco
-
Europe can't afford to miss AI revolution: ECB chief
-
Japanese 'keeper Suzuki signs for Aston Villa
-
Suthar shines as India crush Sri Lanka in 600th Test
EssilorLuxottica sales slide as investors turn wary of AI glasses
Shares in EssilorLuxottica, the world's top maker of eyeglasses, slid on Thursday as analysts said investors have turned wary of AI glasses.
The French-Italian company has pushed hard into wearable tech and has a tie-up with Meta for its Ray-Ban AI glasses.
The nearly five percent drop in morning trading in Paris, whose overall market was up 0.1 percent, came despite the company posting Wednesday evening a 4.1 percent increase in first quarter sales to 7.1 billion euros ($8.3 billion).
EssilorLuxottica did not provide a breakdown of AI glasses, but said they supported growth and the launch of Ray-Ban Meta’s new optical-first styles had been a success.
EssilorLuxottica's foray into "AI glasses is now seen as a source of risk, after initially being viewed as a major opportunity," analysts at Oddo BHF said in a note.
"Following very satisfactory performance in previous quarters, the stock is going through a tougher patch in 2026," they added.
While first quarter sales met analyst expectations, and represented a gain of 10.8 percent on an organic basis -- that is stripping out the effects of changes in exchange rates and in business operations.
But "given the macroeconomic uncertainties, we are cautiously lowering our expectations for organic growth in 2026 from 10 to nine percent," said analysts at Jefferies.
EssilorLuxottica does not provide detailed sales and earnings guidance.
H.Gonzales--AT